SCHEMBL973274

SCHEMBL973274

CN=C(NC)NCc1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.49
▸ HTT P42858 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ TAAR1 Q96RJ0 1/20 0.47
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ HPGD P15428 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL973284 0.78 NPC1 (0.56) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL11595335 0.76 MEN1 (0.66) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL973283 0.76 NPC1 (0.58) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL12851364 0.76 NPC1 (0.79) NPC1RAB9AALDH1A1HTTSMN1; SMN2
Bethanidine SCHEMBL34434 0.75 ALOX12 (0.48) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
Bethanidine SCHEMBL34432 0.75 ALOX12 (0.48) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
Bethanidine SCHEMBL34433 0.75 ALOX12 (0.48) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
Bethanidine SCHEMBL11505129 0.74 MAPT (0.50) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL30259918 0.72 HTT (0.71) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL2910835 0.72 HTT (0.71) NPC1RAB9AALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009446-A1 OLIGOMER-GUANIDINE CLASS CONJUGATES NEKTAR THERAPEUTICS (US) 2011-01-13 — — US claimed
WO-2009089053-A1 OLIGOMER-GUANIDINE CLASS CONJUGATES NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-07-16 — — WO claimed
CN-1228695-C Mechanical control device WANG ZHIHONG (CN) 2005-11-23 — — CN claimed
CN-1367413-A Mechanical control device WANG ZHIHONG (CN) 2002-09-04 — — CN claimed
EP-4203902-B1 HAIR CARE COMPOSITION WITH A ANTIDANDRUFF EFFECT HENKEL AG & CO KGAA (DE) 2026-03-11 — — EP disclosed
EP-4301321-B1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POLYMER-CONTAINING POST-TREATMENT AGENT HENKEL AG & CO KGAA (DE) 2025-11-26 — — EP disclosed
EP-4551302-B1 HAIR CARE COMPOSITION PROCTER & GAMBLE (US) 2025-08-20 — — EP disclosed
EP-4504135-A1 HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION Henkel AG & Co. KGaA (DE) 2025-02-12 — — EP disclosed
EP-4496633-A1 HAIR CONDITIONER FOR SMOOTHING HAIR Henkel AG & Co. KGaA (DE) 2025-01-29 — — EP disclosed
EP-4438130-A2 HAIR CONDITIONING COMPOSITION COMPRISING BRANCHED FATTY ALCOHOL AND TRIESTER The Procter & Gamble Company (US) 2024-10-02 — — EP disclosed
EP-4412577-A1 PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION Henkel AG & Co. KGaA (DE) 2024-08-14 — — EP disclosed
EP-3624898-B1 HAIR CARE COMPOSITION COMPRISING NON-VOLATILE HYDROCARBON OILS AND FATTY ESTERS OF BENZOIC ACID PROCTER & GAMBLE (US) 2024-04-10 — — EP disclosed
WO-2023057147-A1 PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION HENKEL AG & CO. KGAA (DE) 2023-04-13 — — WO disclosed
WO-2022184336-A1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POLYMER-CONTAINING POST-TREATMENT AGENT HENKEL AG & CO. KGAA (DE) 2022-09-09 — — WO disclosed
WO-2022161663-A1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A POST-TREATMENT AGENT HENKEL AG & CO. KGAA (DE) 2022-08-04 — — WO disclosed
WO-2022073696-A1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND, A SEALING REAGENT AND A PRE-TREATMENT AGENT HENKEL AG & CO. KGAA (DE) 2022-04-14 — — WO disclosed
WO-2022063528-A1 TWO-PHASE CARE SPRAY FOR HAIR HENKEL AG & CO. KGAA (DE) 2022-03-31 — — WO disclosed
WO-2022042979-A1 HAIR TREATMENT COMPOSITIONS HAVING ANTIDANDRUFF ACTION HENKEL AG & CO. KGAA (DE) 2022-03-03 — — WO disclosed
US-20110009446-A1 OLIGOMER-GUANIDINE CLASS CONJUGATES NEKTAR THERAPEUTICS (US) 2011-01-13 — — US disclosed
WO-2009089053-A1 OLIGOMER-GUANIDINE CLASS CONJUGATES NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-07-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009446-A1 OLIGOMER-GUANIDINE CLASS CONJUGATES GMPS, OGT, GBA1 NPC1 162/4885RAB9A 1112/4885ALDH1A1 2121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback